肾移植等待名单患者抗HLA抗体动力学的前移植研究
该研究回顾性分析2008至2017年苏黎世大学医院627例肾移植等待者中467例至少两次单抗原珠检测的患者,发现抗HLA抗体平均荧光强度变化与检测间隔无关,而与既往免疫事件(移植、妊娠、输血)相关,尤其既往移植者变化更大,提示个体化监测策略可能优于固定间隔。
要点
- 抗HLA抗体变化与检测间隔无相关性。
- 既往移植史者抗体变化幅度显著更大。
- 建议个体化监测而非固定间隔。
核心结论
- 肾移植等待名单患者的同种免疫动力学与检测间隔无关,而与免疫史相关,提示个体化监测策略可能更优。
研究设计与样本
- 回顾性研究,纳入2008至2017年苏黎世大学医院627例等待肾移植并后续接受移植的患者,其中467例至少两次单抗原珠检测。
主要发现
- 在467例过滤数据集中,连续检测间平均荧光强度变化与检测间隔无相关性。
- 按既往免疫事件分层后,既往移植者与无移植史者之间同种免疫状态变化幅度存在显著差异。
- 基于同种免疫动力学统计特性对患者聚类未成功,提示个体变异性复杂。
临床怎么用
- 临床监测抗HLA抗体时不应仅依赖固定检测间隔,应结合既往移植、妊娠或输血等免疫史制定个体化方案。
局限性
- 回顾性单中心研究,聚类分析未成功,个体变异性复杂,可能限制结论外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients on organ transplant waiting lists are evaluated for preexisting alloimmunity to minimize episodes of acute and chronic rejection by regularly monitoring for changes in alloimmune status. There are few studies on how alloimmunity changes over time in patients on kidney allograft waiting lists, and an apparent lack of research-based evidence supporting currently used monitoring intervals. METHODS: To investigate the dynamics of alloimmune responses directed at HLA antigens, we retrospectively evaluated data on anti-HLA antibodies measured by the single-antigen bead assay from 627 waitlisted patients who subsequently received a kidney transplant at University Hospital Zurich, Switzerland, between 2008 and 2017. Our analysis focused on a filtered dataset comprising 467 patients who had at least two assay measurements. RESULTS: Within the filtered dataset, we analyzed potential changes in mean fluorescence intensity values (reflecting bound anti-HLA antibodies) between consecutive measurements for individual patients in relation to the time interval between measurements. Using multiple approaches, we found no correlation between these two factors. However, when we stratified the dataset on the basis of documented previous immunizing events (transplant, pregnancy, or transfusion), we found significant differences in the magnitude of change in alloimmune status, especially among patients with a previous transplant versus patients without such a history. Further efforts to cluster patients according to statistical properties related to alloimmune status kinetics were unsuccessful, indicating considerable complexity in individual variability. CONCLUSIONS: Alloimmune kinetics in patients on a kidney transplant waiting list do not appear to be related to the interval between measurements, but are instead associated with alloimmunization history. This suggests that an individualized strategy for alloimmune status monitoring may be preferable to currently used intervals.
引用
- Togninalli M, Yoneoka D, Kolios AGA, et al. Pretransplant Kinetics of Anti-HLA Antibodies in Patients on the Waiting List for Kidney Transplantation. J Am Soc Nephrol. 2019. PMID: 31653784. doi:10.1681/ASN.2019060594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。